126 related articles for article (PubMed ID: 19089689)
1. A two-component drug delivery system using Her-2-targeting thermosensitive liposomes.
Kullberg M; Mann K; Owens JL
J Drug Target; 2009 Feb; 17(2):98-107. PubMed ID: 19089689
[TBL] [Abstract][Full Text] [Related]
2. Targeting Her-2+ breast cancer cells with bleomycin immunoliposomes linked to LLO.
Kullberg M; Mann K; Anchordoquy TJ
Mol Pharm; 2012 Jul; 9(7):2000-8. PubMed ID: 22621404
[TBL] [Abstract][Full Text] [Related]
3. Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes.
Kullberg M; Owens JL; Mann K
J Drug Target; 2010 May; 18(4):313-20. PubMed ID: 20201742
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional liposomes having target specificity, temperature-triggered release, and near-infrared fluorescence imaging for tumor-specific chemotherapy.
Kono K; Takashima M; Yuba E; Harada A; Hiramatsu Y; Kitagawa H; Otani T; Maruyama K; Aoshima S
J Control Release; 2015 Oct; 216():69-77. PubMed ID: 26264832
[TBL] [Abstract][Full Text] [Related]
5. HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
Puri A; Kramer-Marek G; Campbell-Massa R; Yavlovich A; Tele SC; Lee SB; Clogston JD; Patri AK; Blumenthal R; Capala J
J Liposome Res; 2008; 18(4):293-307. PubMed ID: 18937120
[TBL] [Abstract][Full Text] [Related]
6. Focused ultrasound influence on calcein-loaded thermosensitive stealth liposomes.
Novell A; Al Sabbagh C; Escoffre JM; Gaillard C; Tsapis N; Fattal E; Bouakaz A
Int J Hyperthermia; 2015 Jun; 31(4):349-58. PubMed ID: 25677841
[TBL] [Abstract][Full Text] [Related]
7. Tumor targeting using anti-her2 immunoliposomes.
Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-triggered herceptin liposomes for breast cancer therapy.
Elamir A; Ajith S; Sawaftah NA; Abuwatfa W; Mukhopadhyay D; Paul V; Al-Sayah MH; Awad N; Husseini GA
Sci Rep; 2021 Apr; 11(1):7545. PubMed ID: 33824356
[TBL] [Abstract][Full Text] [Related]
9. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
10. Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies.
Wei Q; Kullberg EB; Gedda L
Int J Oncol; 2003 Oct; 23(4):1159-65. PubMed ID: 12963999
[TBL] [Abstract][Full Text] [Related]
11. Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.
Chen J; He CQ; Lin AH; Gu W; Chen ZP; Li W; Cai BC
Int J Pharm; 2014 Nov; 475(1-2):408-15. PubMed ID: 25218394
[TBL] [Abstract][Full Text] [Related]
12. Targeted co-delivery of polypyrrole and rapamycin by trastuzumab-conjugated liposomes for combined chemo-photothermal therapy.
Nguyen HT; Tran TH; Thapa RK; Phung CD; Shin BS; Jeong JH; Choi HG; Yong CS; Kim JO
Int J Pharm; 2017 Jul; 527(1-2):61-71. PubMed ID: 28528212
[TBL] [Abstract][Full Text] [Related]
13. Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
Barrajón-Catalán E; Menéndez-Gutiérrez MP; Falco A; Carrato A; Saceda M; Micol V
Cancer Lett; 2010 Apr; 290(2):192-203. PubMed ID: 19896266
[TBL] [Abstract][Full Text] [Related]
14. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.
Eloy JO; Petrilli R; Chesca DL; Saggioro FP; Lee RJ; Marchetti JM
Eur J Pharm Biopharm; 2017 Jun; 115():159-167. PubMed ID: 28257810
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel.
Raju A; Muthu MS; Feng SS
Expert Opin Drug Deliv; 2013 Jun; 10(6):747-60. PubMed ID: 23458409
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of thermosensitive poly(N-(2-hydroxypropyl) methacrylamide mono/dilactate)-grafted liposomes for cancer thermochemotherapy.
van Elk M; van den Dikkenberg JB; Storm G; Hennink WE; Vermonden T; Heger M
Int J Pharm; 2018 Oct; 550(1-2):190-199. PubMed ID: 30130606
[TBL] [Abstract][Full Text] [Related]
17. EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery.
Haeri A; Zalba S; Ten Hagen TL; Dadashzadeh S; Koning GA
Colloids Surf B Biointerfaces; 2016 Oct; 146():657-69. PubMed ID: 27434152
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of liposome extravasation and content release in tumors.
Wu NZ; Braun RD; Gaber MH; Lin GM; Ong ET; Shan S; Papahadjopoulos D; Dewhirst MW
Microcirculation; 1997 Mar; 4(1):83-101. PubMed ID: 9110286
[TBL] [Abstract][Full Text] [Related]
19. Thermosensitive Liposomes for Image-Guided Drug Delivery.
Haemmerich D; Motamarry A
Adv Cancer Res; 2018; 139():121-146. PubMed ID: 29941102
[TBL] [Abstract][Full Text] [Related]
20. Preparation of Immunoliposomes by Direct Coupling of Antibodies Based on a Thioether Bond.
Petrilli R; Eloy JO; Lee RJ; Lopez RFV
Methods Mol Biol; 2018; 1674():229-237. PubMed ID: 28921442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
